Loading clinical trials...
Loading clinical trials...
HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone. A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone. The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Department of Oncology, Vejle Hospital
Vejle, Denmark
Start Date
November 17, 2025
Primary Completion Date
April 1, 2026
Completion Date
December 31, 2026
Last Updated
December 3, 2025
90
ESTIMATED participants
Holistic acupuncture and acupressure
OTHER
Standard medical treatment
OTHER
Lead Sponsor
Vejle Hospital
NCT05245812
NCT05372640
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions